287 related articles for article (PubMed ID: 37190048)
21. Targeting the Microenvironment in Advanced Colorectal Cancer.
Tauriello DVF; Batlle E
Trends Cancer; 2016 Sep; 2(9):495-504. PubMed ID: 28741478
[TBL] [Abstract][Full Text] [Related]
22. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
23. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
24. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.
Ali S; Rehman MU; Yatoo AM; Arafah A; Khan A; Rashid S; Majid S; Ali A; Ali MN
Eur J Pharmacol; 2023 May; 947():175678. PubMed ID: 36990262
[TBL] [Abstract][Full Text] [Related]
25. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8
Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533
[TBL] [Abstract][Full Text] [Related]
26. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
27. ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-β axis in colorectal cancer.
Liu J; Huang Z; Chen HN; Qin S; Chen Y; Jiang J; Zhang Z; Luo M; Ye Q; Xie N; Zhou ZG; Wei Y; Xie K; Huang C
Oncogene; 2021 May; 40(19):3394-3407. PubMed ID: 33875786
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-β1 positive feedback loop.
Zhang Y; Wang S; Lai Q; Fang Y; Wu C; Liu Y; Li Q; Wang X; Gu C; Chen J; Cai J; Li A; Liu S
Cancer Lett; 2020 Oct; 491():22-35. PubMed ID: 32730779
[TBL] [Abstract][Full Text] [Related]
29. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
30. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.
Endo E; Okayama H; Saito K; Nakajima S; Yamada L; Ujiie D; Kase K; Fujita S; Endo H; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2020 Sep; 18(9):1402-1413. PubMed ID: 32493700
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
[TBL] [Abstract][Full Text] [Related]
32. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
Zhang F; Luo Y; Shao Z; Xu L; Liu X; Niu Y; Shi J; Sun X; Liu Y; Ding Y; Zhao L
Cancer Lett; 2016 Apr; 373(2):203-13. PubMed ID: 26820227
[TBL] [Abstract][Full Text] [Related]
34. KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer.
Küçükköse E; Peters NA; Ubink I; van Keulen VAM; Daghighian R; Verheem A; Laoukili J; Kranenburg O
Cell Death Dis; 2022 Jul; 13(7):617. PubMed ID: 35842424
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space-transcriptome analysis.
Kajdaniuk D; Hudy D; Strzelczyk JK; Młynarek K; Słomian S; Potyka A; Szymonik E; Strzelczyk J; Foltyn W; Kos-Kudła B; Marek B
Clin Transl Oncol; 2024 May; 26(5):1229-1239. PubMed ID: 38085441
[TBL] [Abstract][Full Text] [Related]
36. Radiation-Induced Overexpression of TGFβ and PODXL Contributes to Colorectal Cancer Cell Radioresistance through Enhanced Motility.
Lee H; Kong JS; Lee SS; Kim A
Cells; 2021 Aug; 10(8):. PubMed ID: 34440856
[TBL] [Abstract][Full Text] [Related]
37. TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer.
Katagata M; Okayama H; Nakajima S; Saito K; Sato T; Sakuma M; Fukai S; Endo E; Sakamoto W; Saito M; Saze Z; Momma T; Mimura K; Kono K
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894310
[TBL] [Abstract][Full Text] [Related]
38. Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
Guillén Díaz-Maroto N; Sanz-Pamplona R; Berdiel-Acer M; Cimas FJ; García E; Gonçalves-Ribeiro S; Albert N; Garcia-Vicién G; Capella G; Moreno V; Salazar R; Villanueva A; Molleví DG
Clin Cancer Res; 2019 Jul; 25(14):4466-4479. PubMed ID: 30979739
[TBL] [Abstract][Full Text] [Related]
39. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.
Pellatt AJ; Mullany LE; Herrick JS; Sakoda LC; Wolff RK; Samowitz WS; Slattery ML
J Transl Med; 2018 Jul; 16(1):191. PubMed ID: 29986714
[TBL] [Abstract][Full Text] [Related]
40. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
